Single‐ and Multiple‐Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid-Reference-Cited by-同舟云学术

Single‐ and Multiple‐Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid

Published:2014-07-03 Issue:9 Volume:34 Page:891-900
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Flanagan Shawn¹,Fang Edward¹,Muñoz Kelly A.¹,Minassian Sonia L.²,Prokocimer Philippe G.¹

Affiliation:

1. Cubist San Diego California

2. Minassian Biostatistics San Diego California

Funder

Cubist

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.1458

Reference18 articles.

1. Staphylococcus aureus–associated Skin and Soft Tissue Infections in Ambulatory Care

2. Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections

3. U.S. Food and Drug Administration.Guidance for industry—acute bacterial skin and skin structure infections: developing drugs for treatment. Available fromhttp://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071185.pdf. Effective October 2013. Accessed November 13 2013.

4. Trends in the Incidence of Methicillin‐ResistantStaphylococcus aureusInfection in Children’s Hospitals in the United States

5. Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-12

2. Efficacy and Safety of Antibiotics in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections: A Systematic Review and Network Meta-Analysis;Antibiotics;2024-09-10

3. New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?;Pharmaceutics;2024-06-17

4. Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates;Chemical Society Reviews;2024

5. A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects;Antimicrobial Agents and Chemotherapy;2023-11-15